固有再生组:利用间充质微环境和工程化细胞毒性杀伤细胞进行实体瘤免疫治疗
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.
实体瘤通过 MHC I 类分子下调、基质屏障和 T 细胞耗竭逃逸适应性免疫,使传统免疫疗法在“冷”病灶中无效。
60.9分
★★★☆☆
站内排序·非疗效
ALL SOURCES
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.
实体瘤通过 MHC I 类分子下调、基质屏障和 T 细胞耗竭逃逸适应性免疫,使传统免疫疗法在“冷”病灶中无效。
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。